Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock - A biomarker substudy of the IABP-SHOCK II-Trial

European Journal of Heart Failure

Volumn 17, Issue 11, 2015, Pages 1152-1160

  Pöss, Janine ^a   Fuernau, Georg ^a,b   Denks, Daniel ^b   Desch, Steffen ^a,b   Eitel, Ingo ^a,b   De Waha, Suzanne ^b,d   Link, Andreas ^c   Schuler, Gerhard ^b   Adams, Volker ^b   Böhm, Michael ^c   Thiele, Holger ^a,b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d Segeberger Kliniken GmbH   (Germany)

Author keywords

Acute myocardial infarction; Angiopoietin 2; Assist device; Cardiogenic shock; Outcome

Indexed keywords

ANGIOPOIETIN 2; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLEEDING; BLOOD SAMPLING; BLOOD TRANSFUSION; CARDIOGENIC SHOCK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART MUSCLE REPERFUSION; HUMAN; INTRAAORTIC BALLOON PUMP; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT CODING; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL; ADVERSE EFFECTS; BLOOD; CLINICAL TRIAL; COMPLICATION; HEART FAILURE; HEART INFARCTION; HEART STROKE VOLUME; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SHOCK, CARDIOGENIC; TIME FACTOR; TREATMENT OUTCOME;

AGED; ANGIOPOIETIN-2; BIOMARKERS; FEMALE; HEART FAILURE; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SHOCK, CARDIOGENIC; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME;

EID: 84955186607     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.342     Document Type: Article

References (26)

1. Reynolds HR, Hochman JS,. Cardiogenic shock: current concepts and improving outcomes. Circulation 2008; 117: 686-697.
2. van Meurs M, Kumpers P, Ligtenberg JJ, Meertens JH, Molema G, Zijlstra JG,. Bench-to-bedside review: Angiopoietin signalling in critical illness-a future target? Crit Care 2009; 13: 207.
3. Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY,. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. Circ Res 2000; 86: 24-29.
4. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, Sobke A, Herrmann M, Preissner KT, Vajkoczy P, Augustin HG,. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 2006; 12: 235-239.
5. Fiedler U, Scharpfenecker M, Koidl S, Hegen A, Grunow V, Schmidt JM, Kriz W, Thurston G, Augustin HG,. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Paladebodies. Blood 2004; 103: 4150-4156.
6. Pichiule P, Chavez JC, LaManna JC,. Hypoxic regulation of angiopoietin-2 expression in endothelial cells. J Biol Chem 2004; 279: 12171-12180.
7. Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG,. The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci 2005; 118: 771-780.
8. Ong T, McClintock DE, Kallet RH, Ware LB, Matthay MA, Liu KD,. Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients. Crit Care Med 2010; 38: 1845-1851.
9. Kümpers P, Lukasz A, David S, Horn R, Hafer C, Faulhaber-Walter R, Fliser D, Haller H, Kielstein JT,. Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 2008; 12: R147.
10. Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, Sotiropoulou C, Zakynthinos S, Armaganidis A, Papapetropoulos A, Roussos C,. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med 2007; 35: 199-206.
11. Ricciuto DR, dos Santos CC, Hawkes M, Toltl LJ, Conroy AL, Rajwans N, Lafferty EI, Cook DJ, Fox-Robichaud A, Kahnamoui K, Kain KC, Liaw PC, Liles WC,. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med 2011; 39: 702-710.
12. Link A, Pöss J, Rbah R, Barth C, Feth L, Selejan S, Böhm M,. Circulating angiopoietins and cardiovascular mortality in cardiogenic shock. Eur Heart J 2013; 34: 1651-1662.
13. Thiele H, Schuler G, Neumann FJ, Hausleiter J, Olbrich HG, Schwarz B, Hennersdorf M, Empen K, Fuernau G, Desch S, de Waha S, Eitel I, Hambrecht R, Böhm M, Kurowski V, Lauer B, Minden HH, Figulla HR, Braun-Dullaeus RC, Strasser RH, Rochor K, Maier SK, Mollmann H, Schneider S, Ebelt H, Werdan K, Zeymer U,. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J 2012; 163: 938-945.
14. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, de Waha A, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Lauer B, Böhm M, Ebelt H, Schneider S, Werdan K, Schuler G, i. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 2013; 382: 1638-1645.
15. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Böhm M, Ebelt H, Schneider S, Schuler G, Werdan K, Investigators I-SIT,. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287-1296.
16. Fuernau G, Poenisch C, Eitel I, de Waha S, Desch S, Schuler G, Adams V, Werdan K, Zeymer U, Thiele H,. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial. Eur J Heart Fail 2014; 16: 880-887.
17. Lukasz A, Hellpap J, Horn R, Kielstein JT, David S, Haller H, Kumpers P,. Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays. Crit Care 2008; 12: R94.
18. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A,. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31.
19. Lecoutre B., A Correction for the ε approximate test in repeated measures designs with two or more independent groups. J Educ Stat 1991; 16: 371-372.
20. Werdan K, Russ M, Buerke M, Delle-Karth G, Geppert A, Schondube FA, German Cardiac Society; German Society of Intensive Care and Emergency Medicine; German Society for Thoracic and Cardiovascular Surgery; (Austrian Society of Internal and General Intensive Care Medicine; German Interdisciplinary Association of Intensive Care and Emergency Medicine; Austrian Society of Cardiology; German Society of Anaesthesiology and Intensive Care Medicine; German Society of Preventive Medicine and Rehabilitation. Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline. Dtsch Arztebl Int 2012; 109: 343-51.
21. Sallinen H, Heikura T, Koponen J, Kosma VM, Heinonen S, Yla-Herttuala S, Anttila M,. Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer. BMC Cancer 2014; 14: 696.
22. Gerald D, Chintharlapalli S, Augustin HG, Benjamin LE,. Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy. Cancer Res 2013; 73: 1649-1657.
23. David S, Kumpers P, Lukasz A, Fliser D, Martens-Lobenhoffer J, Bode-Boger SM, Kliem V, Haller H, Kielstein JT,. Circulating angiopoietin-2 levels increase with progress of chronic kidney disease. Nephrol Dial Transplant 2010; 25: 2571-2576.
24. Pöss J, Ukena C, Kindermann I, Ehrlich P, Fuernau G, Ewen S, Mahfoud F, Kriechbaum S, Böhm M, Link A,. Angiopoietin-2 and outcome in patients with acute decompensated heart failure. Clin Res Cardiol 2015; 104: 380-387.
25. Kumpers P, Hafer C, David S, Hecker H, Lukasz A, Fliser D, Haller H, Kielstein JT, Faulhaber-Walter R,. Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome. Intensive Care Med 2010; 36: 462-470.
26. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH,. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 1999; 341: 625-634.